文献速递其他结缔组织病

系统性硬化症中的肠-心轴:来自大型前瞻性早期疾病队列的证据

The Gut-Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-06-01

该研究基于459例早期系统性硬化症(SSc)患者的前瞻性队列,中位随访4.1年,发现基线胃肠道受累占59%,随访期间26%出现心脏表现。基线吸收不良和腹胀是未来心脏受累的强预测因素,吸收不良风险最高(HR 10.01,95%CI 3.7-26.9)。上消化道功能障碍与传导缺陷相关,下消化道受累尤其吸收不良与收缩功能障碍相关。

要点

  • 基线吸收不良预测未来心脏受累的HR为10.01(95%CI 3.7-26.9)。
  • 上消化道症状(吞咽困难、消化性溃疡)与传导缺陷显著相关。
  • 下消化道受累尤其吸收不良与收缩功能障碍显著相关。

核心结论

  • 上消化道功能障碍与传导缺陷相关,提示自主神经功能障碍参与。
  • 下消化道受累尤其吸收不良与收缩功能障碍相关,可能提示不同生物学机制。
  • 早期胃肠道症状可支持纳入心脏风险分层。

研究设计与样本

  • 分析459例来自前瞻性 Genetics versus Environment in Scleroderma Outcomes Study 队列的SSc患者。
  • 基线胃肠道受累定义为吞咽困难、胃食管反流病、消化性溃疡、腹胀、腹泻、吸收不良、便秘或假性梗阻中至少一项。
  • 心脏表现包括传导缺陷和收缩功能障碍,采用Cox和多变量逻辑回归模型并调整潜在混杂因素。

主要发现

  • 队列459例SSc患者中82%为女性,中位随访4.1年(四分位距0.8-8.1)。
  • 基线时59%患者有胃肠道受累。
  • 随访期间26%患者出现心脏表现,主要为传导缺陷(24%),收缩功能障碍较少见(5%)。
  • 基线吸收不良和腹胀是未来心脏受累的强预测因素,吸收不良风险最高(HR 10.01,95%CI 3.7-26.9)。
  • 调整潜在混杂因素后,吞咽困难和消化性溃疡与传导缺陷显著相关,吸收不良与收缩功能障碍显著相关。

临床怎么用

  • 可将早期胃肠道症状整合进SSc患者的心脏风险分层。
  • 对基线存在吸收不良或腹胀的SSc患者应警惕未来心脏受累。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cardiac involvement significantly impacts prognosis in systemic sclerosis (SSc), highlighting the need for early risk stratification. Gastrointestinal (GI) symptoms are common and often manifest early. Emerging data suggest a link between GI and cardiac manifestations, possibly through shared mechanisms like dysautonomia. This study investigates the overall association between GI and cardiac involvement in early SSc and evaluates whether baseline GI symptoms predict future cardiac manifestations. METHODS: We analyzed 459 patients from the prospective Genetics versus Environment in Scleroderma Outcomes Study cohort. GI involvement at baseline was defined by one or more of the following: dysphagia, gastroesophageal reflux disease, peptic ulcer, bloating, diarrhea, malabsorption, constipation, or pseudo-obstruction. Cardiac manifestations included conduction defects and systolic dysfunction. Cox and multivariable logistic regression models assessed associations, adjusting for potential confounders. RESULTS: The cohort included 459 patients with SSc (82% female), with a median follow-up of 4.1 years (interquartile range 0.8-8.1). At baseline, 59% of patients had GI involvement. During follow-up, 26% of patients developed cardiac manifestations-mainly conduction defects (24%) and less commonly systolic dysfunction (5%). Baseline malabsorption and bloating were strong predictors of future cardiac involvement, with malabsorption showing the highest risk (hazard ratio 10.01 [95% confidence interval 3.7-26.9]). Interestingly, dysphagia and peptic ulcers were significantly associated with conduction defects, whereas malabsorption was significantly associated with systolic dysfunction, even after adjustment for potential confounders. CONCLUSION: Upper GI dysfunction was associated specifically with conduction defects, suggesting that autonomic dysfunction contributes. In contrast, lower GI involvement, particularly malabsorption, was linked to systolic dysfunction in patients with SSc, potentially indicating a distinct biologic mechanism. These findings may support integrating early GI symptoms into cardiac risk stratification, and they provide a foundation for future translational studies.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Di Ciommo FR, Balar AP, Strother AK, et al. The Gut-Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort. Arthritis Care Res (Hoboken). 2026. PMID: 42223223. doi:10.1002/acr.80097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。